273. Emergence of the SARS-CoV-2 Omicron Variant in the Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED) Study
Stephanie A Richard(Henry M. Jackson Foundation), Timothy Burgess(Uniformed Services University of the Health Sciences), Bruce McClenathan(Womack Army Medical Center), Katrin Mende, Anthony C Fries(Wright-Patterson Air Force Base), Tahaniyat Lalani(Henry M. Jackson Foundation), Catherine M Berjohn(Henry M. Jackson Foundation), Christina Schofield(Madigan Army Medical Center), Wesley Campbell(Walter Reed National Military Medical Center), Alan L. Williams(Walter Reed National Military Medical Center), David Hrncir(Wilford Hall Ambulatory Surgical Center), John H. Powers(Leidos (United States)), Rhonda E Colombo(Henry M. Jackson Foundation), Ana E Markelz(Uniformed Services University of the Health Sciences), Srihari Seshadri(Defense Health Agency), Anuradha Ganesan(Walter Reed National Military Medical Center), Christina Spooner(Defense Health Agency), Tyler Warkentien(Walter Reed National Military Medical Center), Limone Collins(Defense Health Agency), Jitendrakumar Modi(United States Naval Academy)
Cited by 0
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
|Clinical Infectious Diseases|2015|340
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Standardizing Measurement of Chronic Obstructive Pulmonary Disease Exacerbations: Reliability and Validity of a Patient-reported Diary
|American Journal of Respiratory and Critical Care Medicine|2010|182